Early research (Phase 1)Study completedNCT00714103What this trial is testing8-Chloro-Adenosine in Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaChronic Lymphocytic Leukemia M.D. Anderson Cancer Center 11
Early research (Phase 1)Ended earlyNCT05244070What this trial is testingEvaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma Bristol-Myers Squibb 5
Early research (Phase 1)Ended earlyNCT01076556What this trial is testingCyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+9 more National Cancer Institute (NCI) 9
Early research (Phase 1)WithdrawnNCT04094766What this trial is testingSafety and Efficacy of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy in R/R Acute B Lymphoblastic LeukemiaWho this might be right forRefractory B Acute Lymphoblastic LeukemiaRelapse B Acute Lymphoblastic Leukemia Second Affiliated Hospital of Xi'an Jiaotong University
Testing effectiveness (Phase 2)Study completedNCT00003829What this trial is testingChemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 34
Early research (Phase 1)Study completedNCT00036946What this trial is testingVEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific Regeneron Pharmaceuticals
Not applicableNot Yet RecruitingNCT06902025What this trial is testingJY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell LeukemiaWho this might be right forB-ALL He Huang 24
Large-scale testing (Phase 3)Ended earlyNCT00416910What this trial is testingCombination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia German CLL Study Group 83
Early research (Phase 1)Study completedNCT02529813What this trial is testingCD19-Specific T-cells in Treating Patients With Advanced Lymphoid MalignanciesWho this might be right forAcute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaBlasts 5 Percent or More of Bone Marrow Nucleated Cells+6 more M.D. Anderson Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00230282What this trial is testingPhase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaB-cell LeukemiaChronic Leukemia+1 more Steven E. Coutre 25
Testing effectiveness (Phase 2)Study completedNCT01466179What this trial is testingClinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia Amgen Research (Munich) GmbH 225
Post-approval studies (Phase 4)Study completedNCT03677596What this trial is testingTwo Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible PatientsWho this might be right forLeukemiaPrecursor b-Cell Lymphoblastic Leukemia-LymphomaACUTE LYMPHOBLASTIC LEUKEMIA Pfizer 102
Large-scale testing (Phase 3)UnknownNCT00445497What this trial is testingEarly Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile NeutropeniaWho this might be right forBrain and Central Nervous System TumorsLymphomaNeutropenia+3 more Clatterbridge Centre for Oncology 400
Early research (Phase 1)Active Not RecruitingNCT00881920What this trial is testingKappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALLWho this might be right forLymphomaMyelomaLeukemia Baylor College of Medicine 54
Not applicableUnknownNCT02267590What this trial is testingTissue Collection for Biomarkers Determining Resistance to IbrutinibWho this might be right forMantle Cell LymphomaChronic Lymphocytic Leukaemia Royal Marsden NHS Foundation Trust 120
Testing effectiveness (Phase 2)Study completedNCT01024010What this trial is testingOfatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaStage 0 Chronic Lymphocytic LeukemiaStage I Chronic Lymphocytic Leukemia+7 more Mayo Clinic 82
Large-scale testing (Phase 3)Active Not RecruitingNCT03914625What this trial is testingInvestigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaB Lymphoblastic LymphomaDown Syndrome National Cancer Institute (NCI) 6,720
Early research (Phase 1)Study completedNCT00390117What this trial is testingAT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific NCIC Clinical Trials Group 34
Not applicableStudy completedNCT04964908What this trial is testingStudy to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia AstraZeneca 1,088
Testing effectiveness (Phase 2)WithdrawnNCT06247540What this trial is testingVenetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWho this might be right forRecurrent Transformed Chronic Lymphocytic LeukemiaRefractory Transformed Chronic Lymphocytic LeukemiaRichter Syndrome+2 more Northwestern University